Ct Imaging Findings in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: Alternative Response Criteria (choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumor (mrecist)) Versus Recist 1.1
EUROPEAN JOURNAL OF RADIOLOGY（2016）
关键词
Hepatocellular carcinoma,Anti-angiogenic therapy,Tumoral response assessment,RECIST 1.1,mRECIST,Choi
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要